NovAccess Global Inc.
CIK 1039466fmd_1A854EW3NGZK3KVTZMJNC6CGTCManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Oct 01, 1996 to Sep 30, 2024, 71 periods
Latest annual · FY2024
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (1)
- Net income
- (3)
Latest quarter · Q4 FY2024
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (0)
- Net income
- (3)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- n/m
- Revenue, 5 yearsFY2019 to FY2024
- n/m
- Net income, 5 yearsFY2019 to FY2024
- n/m
NovAccess Global Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $0 | 10-K 2026-01-14 · proof | |
| Gross profit | $0 | $0 | 10-K 2026-01-14 · proof | |
| Operating income | -$901,674 | -$2.5 million | 10-K 2026-01-14 · proof | |
| Net income | -$2.7 million | -$4.7 million | 10-K 2026-01-14 · proof | |
| Cash from operating activities | -$215,402 | -$624,636 | 10-K 2026-01-14 · proof | |
| Total assets | $62,224 | $62,248 | 0% | 10-K 2026-01-14 · proof |
| Total liabilities | $10.1 million | $7.9 million | +28.3% | 10-K 2026-01-14 · proof |
| Cash and cash equivalents | $20,891 | $21,415 | -2.4% | 10-K 2026-01-14 · proof |
- What was NovAccess Global Inc.'s revenue in fiscal 2024?
- NovAccess Global Inc. reported revenue of $0 for fiscal 2024 (the year ended Sep 30, 2024), against $0 the year before. Source: the 10-K filed with the SEC on Jan 14, 2026. SEC
- What was NovAccess Global Inc.'s gross profit in fiscal 2024?
- NovAccess Global Inc. reported gross profit of $0 for fiscal 2024 (the year ended Sep 30, 2024), against $0 the year before. Source: the 10-K filed with the SEC on Jan 14, 2026. SEC
- What was NovAccess Global Inc.'s operating income in fiscal 2024?
- NovAccess Global Inc. reported operating income of -$901,674 for fiscal 2024 (the year ended Sep 30, 2024), against -$2.5 million the year before. Source: the 10-K filed with the SEC on Jan 14, 2026. SEC
- What was NovAccess Global Inc.'s net income in fiscal 2024?
- NovAccess Global Inc. reported net income of -$2.7 million for fiscal 2024 (the year ended Sep 30, 2024), against -$4.7 million the year before. Source: the 10-K filed with the SEC on Jan 14, 2026. SEC
- What was NovAccess Global Inc.'s cash from operating activities in fiscal 2024?
- NovAccess Global Inc. reported cash from operating activities of -$215,402 for fiscal 2024 (the year ended Sep 30, 2024), against -$624,636 the year before. Source: the 10-K filed with the SEC on Jan 14, 2026. SEC
- What are NovAccess Global Inc.'s total assets?
- As of Sep 30, 2024, NovAccess Global Inc. reported total assets of $62,224, against $62,248 a year earlier (0%). Source: the 10-K filed with the SEC on Jan 14, 2026. SEC
- What are NovAccess Global Inc.'s total liabilities?
- As of Sep 30, 2024, NovAccess Global Inc. reported total liabilities of $10.1 million, against $7.9 million a year earlier (+28.3%). Source: the 10-K filed with the SEC on Jan 14, 2026. SEC
- What are NovAccess Global Inc.'s cash and cash equivalents?
- As of Sep 30, 2024, NovAccess Global Inc. reported cash and cash equivalents of $20,891, against $21,415 a year earlier (-2.4%). Source: the 10-K filed with the SEC on Jan 14, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1039466&period_type=annual&limit=5"Information only, not investment advice.